Searching:
Search by keyword, patent number, inventor, assignee, city or state:
| Patent # | Description |
|---|---|
| US-4,840,962 |
Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs Pharmaceutical compositions and methods of using same comprising a non-steroidal anti-inflammatory drug in combination with at least one other active component... |
| US-4,840,961 |
Heterocyclic amide derivatives Novel heterocyclic amide derivatives of the formula ##STR1## in which R.sup.1 represents alkyl, or represents alkenyl which has more than 2 carbon atoms and... |
| US-4,840,960 |
Treatment of glomerulonephritis A method for treating a patient suffering from glomerulonephritis comprising administering to the patient an effective amount of nitrendipine. |
| US-4,840,959 |
Pyridinecarboxamide derivatives and their use as fungicide Disclosed are novel pyridinecarboxamide derivatives represented by the general formula: ##STR1## wherein X represents a halogen atom, methyl group or... |
| US-4,840,958 |
Novel 3-hydroxypyrid-2-ones and 3-hydroxyprid-4-ones useful in treating
patients having a toxic concentration... Pharmaceutical compositions containing a 3-hydroxyprid-2-one or 3-hydroxypyrid-4-one in which the hydrogen atom attached to the nitrogen atom is replaced by an... |
| US-4,840,957 |
Pyran derivatives A pyran derivative represented by a general formula ##STR1## wherein R.sub.1 is hydrogen, lower alkyl, cycloalkyl or phenyl, R.sub.2 is alkyl having 8 to 20... |
| US-4,840,956 |
Novel disubstituted-7-pyrrolidinoquinoline antibacterial agents Disubstituted 7-pyrrolidinoquinoline- and -napthylridine-3-carboxylic acids as antibacterial agents are described as well as methods for their manufacture,... |
| US-4,840,955 |
6-substituted-2(1H)-quinolinones and related compounds having use as
cardiotonic, antihypertensive, and... Novel 6-substituted-2(1H)-quinoline and related compounds having usefulness as cardiotonic, antihypertensive, and antithrombotic (platelet aggregation ... |
| US-4,840,954 |
6,7-disubstituted
1-cycloproply-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acids New 6,7-disubstituted-1-cyclopropyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carb oxy lic acids of the formula (I) ##STR1## in which X represents halogen... |
| US-4,840,953 |
9-(Substituted thio)-4H-pyrido[1,2,-A]pyrimidin-4-one derivatives 9-(Substituted thio)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives of the formula: ##STR1## wherein n is 0 or 1, R is --COR.sup.1, --CONR.sup.4 R.sup.5 or... |
| US-4,840,952 |
Method for treatment of male impotence Trazodone and its pharmaceutically acceptable salts are useful in the treatment of male sexual impotence. |
| US-4,840,951 |
Novel naphthalene derivative Naphthalene derivative of the formula: ##STR1## wherein Ring A is a substituted or unsubstituted benzene ring; each of R.sup.1 and R.sup.2 is a group of the... |
| US-4,840,950 |
4-arylcarbonyl-1-[(4-morpholinyl)-lower-alkyl]-1H-indoles 4-Arylcarbonyl-1-[(4-morpholinyl)-lower-alkyl]-1H-indoles, useful as analgesic agents, are prepared by reaction of a 3-arylcarbonyl-2-methylnitrobenzene with DMF... |
| US-4,840,949 |
Oxadiazole-alkyl-purine derivatives useful as antitussive agents The invention relates to new oxidiazole-alkyl-purine-derivatives of the Formula I ##STR1## and pharmaceutically acceptable salts thereof wherein A stands... |
| US-4,840,948 |
1-(hydroxystyrl)-5H-2,3-benzodiazepine derivatives, and pharmaceutical
compositions containing the same This invention relates to new 1-(hydroxystyryl)-5H-2,3-benzodiazepine derivatives of the general formula (I) and to a process for the preparation thereof,... |
| US-4,840,947 |
Antiinflammatory and analgesic piperidin-4-yl-tetracyclic
benzodiazepines and use thereas There are disclosed compounds of the formula ##STR1## where X and Y are independently hydrogen, loweralkyl, halogen or trifluoromethyl; Z is --CH.sub.2... |
| US-4,840,946 |
Benzazolythio-carbapenem antibiotics Antibiotically active benzazolylthio-carbapenems of the formula ##STR1## in which R.sup.1 represents hydrogen or a hydroxyl-protecting group, R.sup.2 represents... |
| US-4,840,945 |
Cephalosporin derivatives The present invention relates to novel cephalosporin derivatives, processes for preparing thereof, compositions for preventing and/or treating infectious... |
| US-4,840,944 |
Antibacterial beta-lactams, pharmaceuticals thereof and methods of using
them The present invention relates to hitherto unknown compounds of the general formula I: ##STR1## in which R.sub.1 stands for a phenyl, 4-hydroxyphenyl,... |
| US-4,840,943 |
Androst-4-ene-3,17-diones and process for their preparation The present invention relates to new 6-substituted 1.2.beta.methylenandrost-4-ene-3,17-diones of the following general formula: ##STR1## wherein one of... |
| US-4,840,942 |
Emulsifying dispersant and biocidal composition containing same An emulsifying dispersant is disclosed which is a nonionic surface active agent substantially free of a terminal primary hydroxyl group, obtained by esterifying... |
| US-4,840,941 |
Method for inhibiting infection of human T-cells Method of treatment of diseases caused by retroviruses which comprises administering therapeutically effective amount of a natural or synthetic oligo- or... |
| US-4,840,940 |
Method for reducing the occurrence of distal anastomotic intimal
hyperplasia using fractionated heparin A method is provided for reducing the occurrence of anastomotic intimal hyperplasia in grafts of artery, vein, biologic or synthetic conduits having end-to-side... |
| US-4,840,939 |
Treatment of cancer with phlorizin and its derivatives Malignant, neoplastic cells are treated by inhibiting glucose transport into the cell by administering phlorizin, phloretin or its analogs while concurrently... |
| US-4,840,938 |
Pharmaceutical compositions containing anthracycline glycosides Stable, rapidly soluble, lyophilized injectable preparations comprising an anthracycline glycoside, or a pharmaceutically acceptable salt thereof, as the active... |
| US-4,840,937 |
Surfactant composed of acylated collagen or acylated gelatine and a
production process thereof This invention relates to a surfactant with less toxicity and irritation against the human body and a production process thereof. The surfactant is produced by... |
| US-4,840,936 |
Pharmaceutically useful derivatives of thiazolidine-4-carboxylic acid Compounds of formula ##STR1## in which R, R.sub.1 and Y have the meanings shown in the description, their preparation by condensing an aldehyde or a ketone... |
| US-4,840,935 |
Peptide amino-alcohol derivatives containing a tetrasubstituted carbon
atom, inhibiting renin and acid... The present invention relates to peptide amino-alcohol derivatives containing a tetra substituted carbon atom. Said peptides inhibit the renin and acid... |
| US-4,840,934 |
Therapeutic method using T cell growth factor Therapeutic methods and compositions using TCGF from HSB-2-ERICR cells and its mutants are disclosed. |
| US-4,840,933 |
Heat sensitive recording material A heat sensitive recording material which comprises a support having thereon a heat sensitive layer containing at least color former-contained microcapsules and... |
| US-4,840,932 |
Catalyst for producing 1,4-naphthoquinone A process for producing 1,4-naphthoquinone by oxidizing naphthalene with molecular oxygen in a vapor phase in the presence of a catalyst. The catalyst is made of... |
| US-4,840,931 |
Method of inducing surface ensembles on a metal catalyst A method of inducing surface ensembles on a transition metal catalyst used in the conversion of a reactant gas or gas mixture, such as carbon monoxide and... |
| US-4,840,930 |
Method for preparing acid stable zeolites and high silica zeolites
prepared by it Zeolite Y and other faujasite type zeolites are made stable to acid by calcination in a steam-containing atmosphere with a slow, controlled heating rate in the... |
| US-4,840,929 |
Zeolite beta with improved regeneration characteristics The present invention describes a method for preparing a noble metal Zeolite Beta containing catalyst with improved platinum redispersion characteristics. The... |
| US-4,840,928 |
Conversion of alkanes to alkylenes in an external catalyst cooler for
the regenerator of a FCC unit Lower alkanes are converted to olefins in a `third bed` external catalyst cooler (ECC) in which hot catalyst, from the regenerator (`second bed`) operating in... |
| US-4,840,927 |
Desensitizer composition A desensitizer composition consisting essentially of a 2,2,6,6-tetramethylpyperidine compound as a desensitizer and additives comprising a natural or synthetic... |
| US-4,840,926 |
High frequency wave absorbing ceramics A high frequency wave absorbing ceramics can be used, for example, as an EMI preventive filter for interrupting high frequency waves intruding into electronic... |
| US-4,840,925 |
Compositions of transition metal manganites in the form of particles or
ceramics, their preparation and their... A manganite type composition of the formula wherein M is at least one metal selected from Cu, Zn and Cd, y and z range from 0 to 1, and (x+y+z) is lower than 2. This... |
| US-4,840,924 |
Method of fabricating a multichip package A multichip package comprises a multilayer wiring substrate, and an array of contact pads having the ability to make wiring change formed on an uppermost layer... |
| US-4,840,923 |
Simultaneous multiple level interconnection process A system of establishing a conductive via path between spaced interlevel conductors. Successive layers of metallization separated by a dielectric are built. The... |
| US-4,840,922 |
Method of manufacturing masked semiconductor laser A masking layer is formed on the light-emitting mirror surface of a semiconductor laser body. The masking layer is capable of blocking or cutting off light... |
| US-4,840,921 |
Process for the growth of III-V group compound semiconductor crystal on
a Si substrate In a process for the growth of III-V group compound semiconductor crystal on a Si substrate, chloride gas of an element selected from In and Ga of III group... |
| US-4,840,920 |
Method of isolating a semiconductor device using local oxidation In a method of manufacturing a semiconductor device according to the present invention, regions of first conductivity type buried layers formed on a first... |
| US-4,840,919 |
Gas dosimeter for colorimetrically indicating the presence of amides A gas dosimeter utilizing a colorimetric reagent for the selective determination of total amines in solution or in air is described. The reagent comprises 1,2... |
| US-4,840,918 |
Method of noise reduction in CCD solid state imagers A method to reduce the dark current in CCD solid state imagers is disclosed. This method involves sintering an unpatterned Al film on top of an oxide layer at... |
| US-4,840,917 |
Method of interface state reduction in MNOS capacitors A method to reduce the interface state density in MNOS (Conductor-Nitride-Oxide-Semiconductor) is disclosed. This method involves sintering an unpatterned Al... |
| US-4,840,916 |
Process for fabricating an avalanche photodiode Disclosed is an avalanche photodiode wherein a light absorption layer and a multiplication layer are first grown on substrate. The multiplication layer is then... |
| US-4,840,915 |
Method for diagnosing malignant tumors This invention is directed to a novel group of compounds, herein termed Recognins. Recognins are made by treating malignant tumor cells or artificial cancer... |
| US-4,840,914 |
Gender-indicating colormetric test on pregnancy urine and test kit
therefor A gender-indicating test of the unborn child is provided. It is a colorimetric test on the pregnancy urine performed on samples obtained after about the 20th... |
| US-4,840,913 |
Oxides of nitrogen detector A structure and method for sensing oxides of nitrogen in a gas. The gas is first passed through an oxidation catalyst and any reducing species in the gas are... |
Copyright 2008−2012 Patents.com
